Benzinga's Top Initiations

Analysts at Mizuho Securities initiated coverage on shares of OncoMed (NASDAQ: OMED ) with a “buy” rating. The target price for OncoMed is set to $45. OncoMed's shares closed at $31.47 yesterday. Analysts at Drexel Hamilton initiated coverage on shares of Verizon Communications (NYSE: VZ ) with a “hold”